Compare CSW & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSW | BCPC |
|---|---|---|
| Founded | 2014 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Major Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.6B |
| IPO Year | N/A | N/A |
| Metric | CSW | BCPC |
|---|---|---|
| Price | $322.01 | $178.67 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $307.25 | $176.00 |
| AVG Volume (30 Days) | ★ 190.7K | 158.7K |
| Earning Date | 01-29-2026 | 02-20-2026 |
| Dividend Yield | 0.34% | ★ 0.55% |
| EPS Growth | N/A | ★ 22.48 |
| EPS | ★ 7.55 | 4.57 |
| Revenue | $1,004,138,000.00 | ★ $1,013,548,000.00 |
| Revenue This Year | $23.76 | $10.41 |
| Revenue Next Year | $17.11 | $6.36 |
| P/E Ratio | $41.70 | ★ $38.21 |
| Revenue Growth | ★ 16.95 | 7.55 |
| 52 Week Low | $230.45 | $139.17 |
| 52 Week High | $338.90 | $177.40 |
| Indicator | CSW | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 60.24 | 72.88 |
| Support Level | $256.64 | $169.73 |
| Resistance Level | $279.37 | $176.55 |
| Average True Range (ATR) | 13.36 | 3.52 |
| MACD | 2.41 | 0.36 |
| Stochastic Oscillator | 84.41 | 99.85 |
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.